Eledon Pharmaceuticals's market cap is currently $259.27M. The company's EPS TTM is $-5.71; its P/E ratio is ―; Eledon Pharmaceuticals is scheduled to report earnings on March 27, 2025, and the estimated EPS forecast is $-0.31. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Dec 22	Dec 21	Dec 20	Dec 19
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00	$ 120.00K	$ 0.00
Gross Profit	$ -374.00K	$ -373.00K	$ -195.00K	$ -63.00K	$ -182.00K
Operating Income	$ -43.00M	$ 8.49M	$ -36.87M	$ -18.46M	$ -16.05M
EBITDA	$ 0.00	$ -87.59M	$ -36.66M	$ -23.03M	$ -15.83M
Net Income	$ -40.33M	$ -87.50M	$ -34.51M	$ -22.81M	$ -17.88M
Balance Sheet
Cash & Short-Term Investments	$ 51.10M	$ 56.41M	$ 84.83M	$ 114.19M	$ 8.79M
Total Assets	$ 89.07M	$ 92.79M	$ 170.55M	$ 197.19M	$ 10.93M
Total Debt	$ 383.00K	$ 746.00K	$ 769.00K	$ 144.00K	$ 324.00K
Net Debt	$ -4.23M	$ -55.66M	$ -84.06M	$ -114.05M	$ -8.47M
Total Liabilities	$ 81.86M	$ 8.61M	$ 6.55M	$ 6.59M	$ 1.47M
Stockholders' Equity	$ 7.21M	$ 84.18M	$ 164.00M	$ 190.60M	$ 9.46M
Cash Flow
Free Cash Flow	$ -39.53M	$ -28.42M	$ -28.91M	$ -15.21M	$ -13.86M
Operating Cash Flow	$ -39.53M	$ -28.42M	$ -28.91M	$ -15.21M	$ -13.86M
Investing Cash Flow	$ -45.29M	$ 0.00	$ 0.00	$ 11.04M	$ 0.00
Financing Cash Flow	$ 33.02M	$ 0.00	$ -449.00K	$ 109.58M	$ 9.68M

Currency in USD

Eledon Pharmaceuticals Earnings and Revenue History

Income Statement >

Eledon Pharmaceuticals Debt to Assets

Balance Sheet >

Eledon Pharmaceuticals Cash Flow

Cash Flow >

Eledon Pharmaceuticals Forecast EPS vs Actual EPS

Earnings >

Become an Expert with TipRanks Premium

What am I Missing?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing